HANK & LIN'S GROUP

The past is prologue and the future is scintillating

  • Hank Kung, Seok Choi, Karl Ploessl, Zhihao Zha and Zehui Wu. New 68Ga Glu-Urea-Lys(Ahx)-HBED-CC-bisphosponate as a dual-targeted imaging agent for PSMA and bone metastasis.Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1395

[68Ga]1可能适合作为PSMA和骨转移的双重靶向显像剂。可能在检测骨转移方面表现出更高的敏感性和特异性。

  • Zhihao Zha, Karl Ploessl, Seok Rye Choi, Ruiyue Zhao, Wenbin Jin, Ran Wang, David Alexoff, Lin Zhu and Hank F. Kung. "Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy". J Med Chem. 2023 66 (17), 12602-12613
  • Yang Luo,Wenbin Jin,Ran Wang,Ruiyue Zhao,Lin Zhu*,Hank F. Kung*. 68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer. J. Med. Chem. 2024, 67 (15), 13491-13506
unsplash